Apolipoprotein A1 is associated with pulmonary vascular resistance and adverse clinical outcomes in patients with pulmonary hypertension secondary to heart failure

Pulmonary hypertension secondary to heart failure (HF‐PH) combined with pulmonary vascular remodeling has a high mortality rate. Apolipoprotein A1 (ApoA1) has been shown to adversely affect outcomes in patients with HF. A prospective follow‐up study was performed on 239 consecutive patients with HF‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Wande, Dujiang, Xie, Yi, Wang, Guanwen, Ding, Mengyu, Zhang, Chang, Pan, Aikai, Zhang, Juan, Zhang, Linlin, Zhu, Hang, Zhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326519/
https://www.ncbi.nlm.nih.gov/pubmed/35911182
http://dx.doi.org/10.1002/pul2.12096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326519/
https://www.ncbi.nlm.nih.gov/pubmed/35911182
http://dx.doi.org/10.1002/pul2.12096

Ejemplares similares